The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 16, 2016

Filed:

Aug. 26, 2013
Applicants:

Gerard Zurawski, Midlothian, TX (US);

Jacques Banchereau, Dallas, TX (US);

Anne-laure Flamar, Dallas, TX (US);

Yves Levy, Paris, FR;

Monica Montes, Dallas, TX (US);

Inventors:

Gerard Zurawski, Midlothian, TX (US);

Jacques Banchereau, Dallas, TX (US);

Anne-Laure Flamar, Dallas, TX (US);

Yves Levy, Paris, FR;

Monica Montes, Dallas, TX (US);

Assignee:

Baylor Research Institute, Dallas, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); A61K 39/21 (2006.01); A61K 39/295 (2006.01); C07K 2/00 (2006.01); C12P 21/08 (2006.01); C07K 19/00 (2006.01); C07K 16/28 (2006.01); C07K 14/005 (2006.01); A61K 39/385 (2006.01); G01N 33/68 (2006.01); C07K 16/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2878 (2013.01); A61K 39/385 (2013.01); C07K 14/005 (2013.01); C07K 16/00 (2013.01); G01N 33/6863 (2013.01); A61K 2039/6056 (2013.01); A61K 2039/627 (2013.01); A61K 2039/64 (2013.01); C07K 2317/41 (2013.01); C07K 2317/77 (2013.01); C07K 2319/00 (2013.01); C07K 2319/30 (2013.01); C07K 2319/40 (2013.01); C12N 2740/16222 (2013.01); C12N 2740/16322 (2013.01); C12N 2760/16122 (2013.01); C12N 2770/24222 (2013.01); C12N 2770/24234 (2013.01);
Abstract

The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccines and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies.


Find Patent Forward Citations

Loading…